Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Short-term Investments: 2020-2024

Historic Short-term Investments for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $188.4 million.

  • Tango Therapeutics' Short-term Investments fell 60.66% to $94.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.5 million, marking a year-over-year decrease of 60.66%. This contributed to the annual value of $188.4 million for FY2024, which is 30.36% down from last year.
  • Tango Therapeutics' Short-term Investments amounted to $188.4 million in FY2024, which was down 30.36% from $270.5 million recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' Short-term Investments ranged from a high of $342.5 million in FY2021 and a low of $161.9 million during FY2020.
  • Over the past 3 years, Tango Therapeutics' median Short-term Investments value was $270.5 million (recorded in 2023), while the average stood at $255.0 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 111.51% in 2021, then crashed by 30.36% in 2024.
  • Tango Therapeutics' Short-term Investments (Yearly) stood at $161.9 million in 2020, then soared by 111.51% to $342.5 million in 2021, then decreased by 10.61% to $306.2 million in 2022, then dropped by 11.65% to $270.5 million in 2023, then tumbled by 30.36% to $188.4 million in 2024.